Pathway Summary for IL22

Overview

Interleukin-22 (IL-22) is a secreted cytokine of the IL-10 family that plays critical roles in innate immunity, tissue repair, and inflammation at barrier surfaces. Unlike most cytokines, IL-22 acts primarily on non-immune cells (epithelial cells, hepatocytes) through the IL-22R1/IL-10RB receptor complex, activating JAK-STAT signaling to promote antimicrobial defense, epithelial proliferation, and tissue regeneration. IL-22 is produced mainly by activated T cells (Th17/Th22) and innate lymphoid cells (ILC3).

Core Signaling Pathways

IL-22R/JAK-STAT Pathway

IL-22 binding to IL-22R1/IL-10RB heterodimeric receptor activates JAK1/TYK2, leading to STAT3 phosphorylation (primary), with additional activation of STAT1 and STAT5. Phosphorylated STATs translocate to nucleus to induce antimicrobial peptides, proliferation genes, and tissue repair factors.

Tissue Protection and Regeneration

IL-22 promotes epithelial cell survival and proliferation through:
- Anti-apoptotic protein expression (BCL-2, BCL-xL)
- Cell cycle progression genes
- Stem cell activation and tissue regeneration

Antimicrobial Defense

IL-22 induces expression of antimicrobial proteins at barrier surfaces:
- β-defensins, S100 proteins, RegIII family
- Mucins for barrier protection
- Complement components

Pathway Diagram

graph TD A[IL-22: Cytokine] --> B["IL-22R1/IL-10RB: Receptor (Epithelial Cells)"] B --> C[JAK1/TYK2: Kinases] C -->|phosphorylation| D[STAT3: Primary] C -->|phosphorylation| E[STAT1: Secondary] C -->|phosphorylation| F[STAT5: Minor] G[IL-22BP/IL-22RA2: Soluble Antagonist] --|blocks| A D --> H[Nucleus] H --> I[Antimicrobial Peptides] I --> J[β-defensins, RegIIIγ, S100A7] D --> K[Proliferation Genes] K --> L[Tissue Repair] D --> M[BCL-2, BCL-xL] M --> N[Cell Survival] O[Th17/Th22 Cells] -->|produce| A P[ILC3] -->|produce| A Q[IL-23, IL-1β] -->|induce| O R[MAPK Pathway] <-.-> C S[PI3K/AKT] <-.-> C style A fill:#f9f,stroke:#333,stroke-width:2px style D fill:#ffd,stroke:#333,stroke-width:1px

Upstream Regulation

Cellular sources: Th17, Th22, ILC3, γδ T cells, NKT cells
Inducing cytokines: IL-23, IL-1β, IL-6, TGF-β
Transcription factors: RORγt, AHR, STAT3 in producing cells
Negative regulation: IL-22BP soluble receptor antagonist

Downstream Effects

Antimicrobial Response

Defensins: HBD2, HBD3
S100 proteins: S100A7, S100A8/9
RegIII family: RegIIIα, RegIIIγ
Lipocalin-2: Iron sequestration

Tissue Repair

Proliferation markers: Ki67, PCNA
Wound healing factors: MMP1, MMP3
Mucins: MUC1, MUC3, MUC10, MUC13

Metabolic Effects

Hepatocytes: Acute phase proteins
Lipid metabolism: Apolipoprotein regulation
Glucose metabolism: Affects insulin sensitivity

Clinical Significance

Protective Roles

Inflammatory bowel disease: Epithelial repair
Psoriasis: Paradoxical protective/pathogenic roles
Infections: Defense against extracellular bacteria

Pathogenic Roles

Psoriasis: Excessive keratinocyte proliferation
Rheumatoid arthritis: Synovial inflammation
Cancer: Tumor-promoting in some contexts

Regulatory Mechanisms

IL-22BP: Natural antagonist controlling IL-22 activity
Tissue distribution: Receptor expression limited to non-hematopoietic cells
SOCS proteins: Negative feedback on STAT signaling
Context-dependent: Protective vs pathogenic based on timing/amount

Tissue-Specific Functions

Intestinal epithelium: Barrier integrity, antimicrobial defense
Skin: Keratinocyte proliferation, wound healing
Liver: Hepatoprotection, acute phase response
Lung: Epithelial repair, antimicrobial immunity
Pancreas: β-cell protection

Integration with Immune Networks

Type 3 immunity: Core effector cytokine with IL-17
Th17/ILC3 axis: Barrier surface immunity
Microbiome interaction: Maintains host-microbe homeostasis
Tissue-immune crosstalk: Bridge between immune and stromal cells